Identification of STAB1 in Multiple Datasets as a Prognostic Factor for Cytogenetically Normal AML: Mechanism and Drug Indications-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of STAB1 in Multiple Datasets as a Prognostic Factor for Cytogenetically Normal AML: Mechanism and Drug Indications

Published:2019-12 Issue: Volume:18 Page:476-484
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Lin Sheng-Yan,Hu Fei-Fei,Miao Ya-Ru,Hu Hui,Lei Qian,Zhang Qiong,Li Qiubai,Wang Hongxiang,Chen Zhichao,Guo An-Yuan

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference33 articles.

1. Acute myeloid leukemia;Döhner;N. Engl. J. Med.,2015

2. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia;Ley;N. Engl. J. Med.,2013

3. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel;Döhner;Blood,2017

4. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia;Patel;N. Engl. J. Med.,2012

5. High levels of Wilms’ tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome;Bergmann;Blood,1997

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A machine learning model identifies M3-like subtype in AML based on PML/RARα targets;iScience;2024-02

2. Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial;Cell Reports Medicine;2023-12

3. Growth inhibition of RAS-mutated hematopoietic tumor cells using glucose-attached reversibly ionic oligonucleotide-based nanoparticles caging chemically modified microRNA143-3p;Journal of Drug Delivery Science and Technology;2023-10

4. Targeting cytohesin-1 suppresses acute myeloid leukemia progression and overcomes resistance to ABT-199;Acta Pharmacologica Sinica;2023-08-29

5. Exploring Prognostic Biomarkers of Acute Myeloid Leukemia to Determine Its Most Effective Drugs from the FDA-Approved List through Molecular Docking and Dynamic Simulation;BioMed Research International;2023-06-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3